Valiant Express
- Manufacturer
- ABS Global Inc.
- Effective date
- 2018-05-29
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 02:40:16
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SAFE HANDLING WARNING SECTION
KEEP OUT OF REACH OF CHILDREN
NOT FOR HUMAN USE
Danger
Causes severe skin burns and eye damage.
Wash skin thoroughly after handling. Wear protective gloves/ protective clothing/ eye protection/ face protection.
Do not mix with bleach or other chlorinated products – will cause chlorine gas.
IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
IF ON SKIN (or hair): Remove/ Take off immediately all contaminated clothing. Rinse skin with water/ shower.
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor/ physician.
Wash contaminated clothing before reuse.
VETERINARY INDICATIONS SECTION
DIRECTIONS FOR USE
Mix Directions: If not using an automated pump system, then mix according to the following directions.
1. Measure one part of Express 1 Concentrate component into a clean empty, non-metallic container.
2. Add 20 parts cool potable water (at or below 77°F/25°C.)
3. Add one part Express 3 Concentrate component and mix.
4. This mixed solution Express 1 & 3 RTU (ready-to-use) will remain stable for 24 hours. After 24 hours discard any remaining solution and mix a new solution.
IMPORTANT: Do not add mixed Express 1 & 3 RTU ready-to-use to any other teat dip or other products. If transferred from this container to any other, make sure the other container is thoroughly pre-cleaned and bears the proper container labeling for Express 1 & 3 RTU. Use of a complete cow-care program including both pre and post dipping may aid in reducing the spread of organisms which may cause mastitis.
DIRECTIONS FOR TEAT DIPPING
Pre-Milking: Fill teat dip cup with Express 1 & 3 RTU. Before each cow is milked, dip the teats as far as possible into the teat dip cup containing Express 1 & 3 RTU. Wipe teats dry after dipping, using single-service towels to avoid contamination of milk.
Udder and teats which are heavily soiled should be washed before using a pre-milking teat dip. Teats should be dried with a single-service towel and dipped in Express 1 & 3 RTU, wiping teats dry before milking.
Post-Milking: Immediately after milking, use Express 1 & 3 RTU at full strength. Submerge teat 2/3 their length in Express 1 & 3 RTU teat dip. Allow to air dry. Do not wipe.
Always use fresh full strength Express 1 & 3 RTU. If product in dip cup becomes visibly dirty, discard contents and replenish with fresh product. Do not reuse or return unused product to the original container.
Do not turn cows into freezing weather until Express 1 & 3 RTU is completely dry.
NOTE: Express 1 & 3 RTU is not intended to cure or help in the healing of chapped or irritated teats. In case of irritation or chapping, have the condition examined and, if necessary, treated by a veterinarian. Pre-Milking: Fill teat dip cup with Express 1 & 3 RTU. Before each cow is milked, dip the teats as far as possible into the teat dip cup containing Express 1 & 3 RTU. Wipe teats dry after dipping, using single-service towels to avoid contamination of milk.
OTHER SAFETY INFORMATION
READ SAFETY DATA SHEET (SDS) BEFORE USING THIS PRODUCT
EMERGENCY HEALTH INFORMATION: 1 800 328 0026. If located outside the United States and Canada, call collect 1 651 222 5352 (number is in the US).
Representative label and principal display panel
Valiant
Express™ 1 Concentrate
quality milk system
ABS
Unique Teat Dip Concentrate Compound
DO NOT MIX EXPRESS 1 AND EXPRESS 3 DIRECTLY TOGETHER
When properly mixed with potable water and Express 3, this solution is an aid in reducing the
spread of organisms which may cause mastitis.
ACTIVE INGREDIENTS:
Lactic Acid....................................................................................................9.5%
Linear Dodecyl Benzene Sulfonic Acid...............................................................1.6%
INERT INGREDIENTS:................................................................................ 88.9%
(contains lanolin, propylene glycol)
TOTAL:.......................................................................................................100.0%
6300622
208 L (55 US GAL)
Distributed by:
ABS Global, Inc. · P.O. Box 459
DeForest, Wisconsin USA 53532
Manufactured by:
Ecolab ∙ 1 Ecolab Place ∙ St. Paul MN 55102 USA ·
tel: 1 800 392 3392
© 2017 Ecolab USA Inc · All rights reserved | Todos los derechos reservados
Made in U.S.A. | Hecho en EE.UU
www.ecolab.com · 753671/5302/0418
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1421080 | lactic acid 9.5 % / dodecylbenzenesulfonic acid 1.6 % Topical Solution | PSN | 4 |
| 1421080 | dodecylbenzenesulfonic acid 16 MG/ML / lactic acid 95 MG/ML Topical Solution | SCD | 4 |
| 1421080 | dodecylbenzenesulfonic acid 1.6 % / lactic acid 9.5 % Topical Solution | SY | 4 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LACTIC ACID, UNSPECIFIED FORM Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20220121 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59282-103-17 | Valiant Express | 56780 mL in 1 DRUM | SOLUTION | 56780 | 4 | |
| 59282-103-21 | Valiant Express | 208200 mL in 1 DRUM | SOLUTION | 208200 | 4 | |
| 59282-103-44 | Valiant Express | 1134000 mL in 1 CONTAINER | SOLUTION | 1134000 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DODECYLBENZENESULFONIC ACID | ACTIVE INGREDIENT | 60NSK897G9 | 2 | |
| LACTIC ACID | ACTIVE INGREDIENT | 33X04XA5AT | 2 | |
| DODECYLBENZENESULFONIC ACID | ACTIVE MOIETY | 60NSK897G9 | 2 | |
| LACTIC ACID | ACTIVE MOIETY | 33X04XA5AT | 2 | |
| LANOLIN | INACTIVE INGREDIENT | 7EV65EAW6H | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Valiant Express
- Lactic Acid and Dodecyl Benzene Sulfonic Acid
- LACTIC ACID
- DODECYLBENZENESULFONIC ACID
- PROPYLENE GLYCOL
- PEG-75 LANOLIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 59282-103 | 59282-103-17, 59282-103-21, 59282-103-44 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTIC ACID | 33X04XA5AT | ACTIB |
| DODECYLBENZENESULFONIC ACID | 60NSK897G9 | ACTIB |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PEG-75 LANOLIN | 09179OX7TB | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 63.4 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | JELLY / TOPICAL | 20 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / TOPICAL | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | 7459 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / INTRAVENOUS | 50.33 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO, SUSPENSION / TOPICAL | 2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TAMPON / VAGINAL | 62.1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CLOTH / TOPICAL | 0.03 mg/mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / SUBLINGUAL | 36 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SHAMPOO / TOPICAL | 2 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / VAGINAL | 2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYSTEM / TOPICAL | 4200 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, SOLUBLE / BUCCAL | 5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / TOPICAL | 5.28 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | LOTION / TOPICAL | 1.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT, AUGMENTED / TOPICAL | 714 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TRANSDERMAL | 500 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
